HTS 30
Medical
Duty rates below are a curated snapshot of the HTS schedule, not a live USITC feed. Verify entries against the official HTS before filing. Verify on the official USITC HTS
3004.90.92General duty rate: Free
Pharmaceutical products, packaged for retail sale
Most pharmaceuticals are duty-free
Tariff measures affecting this code
Section 232 pharmaceutical tariffs (phased in from July 31, 2026)
The April 2026 proclamation imposes pharmaceutical tariffs in two phases. Duties have applied since July 31, 2026 to companies listed in Annex III; other companies are scheduled for September 29, 2026. The default rate on patented pharmaceuticals and ingredients is 100%, with 15% treatment for the EU, Japan, South Korea, and Switzerland, zero for the UK, and 20% or 0% for companies with approved U.S. onshoring agreements. Generics remain excluded for now.
Current rate: For covered Annex III companies: 100% default on patented pharmaceuticals; 15% EU/JP/KR/CH; 0% UK; 20% or 0% under approved company agreements
Scheduled escalation:Could this affect a product?
Compare one HTS code and origin with the selected measures in the curated dataset. No account required.